1. To identify a surface marker that might be use as prediction of engineering cartilaginous tissue quality, and to use these markers for sorting of more highly chondrogenic subpopulations
2. To produce and characterize spectific mAb to human chondroctye surface antigen
3 To use the antibody on identifying monitoring the chondrocyte functions and cartilage degradation.
